HOXD-AS2 and glioblastoma: In summary, our study described a HOXD‐AS2‐STAT3 positive feedback loop which attenuates TMZ sensitivity in glioblastoma and it revealed clinical implications involving HOXD‐AS2 and TMZ sensitivity.